Cargando…

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ackerman, Margaret E., Mikhailova, Anastassia, Brown, Eric P., Dowell, Karen G., Walker, Bruce D., Bailey-Kellogg, Chris, Suscovich, Todd J., Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706315/ https://www.ncbi.nlm.nih.gov/pubmed/26745376 http://dx.doi.org/10.1371/journal.ppat.1005315

Ejemplares similares

High‐resolution definition of humoral immune response correlates of effective immunity against HIV
por: Alter, Galit, et al.
Publicado: (2018)

Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
por: Gunn, Bronwyn M, et al.
Publicado: (2020)

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
por: Brown, Eric P., et al.
Publicado: (2018)

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees
por: Choi, Ickwon, et al.
Publicado: (2015)

Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children
por: Brinkman, Iris D, et al.
Publicado: (2021)

Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells
por: Rossignol, Evan D., et al.
Publicado: (2021)

Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
por: Natarajan, Harini, et al.
Publicado: (2021)

Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers
por: Kant, Sanket, et al.
Publicado: (2020)

Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies
por: Sips, Magdalena, et al.
Publicado: (2016)

Mining for humoral correlates of HIV control and latent reservoir size
por: Das, Jishnu, et al.
Publicado: (2020)

Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies
por: Dugast, Anne-Sophie, et al.
Publicado: (2014)

Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features
por: Cheng, Hao D., et al.
Publicado: (2021)

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation()
por: Fischinger, Stephanie, et al.
Publicado: (2019)

Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site
por: Cheng, Hao D., et al.
Publicado: (2018)

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
por: Gunn, Bronwyn, et al.
Publicado: (2016)

NK Cells in HIV Disease
por: Scully, Eileen, et al.
Publicado: (2016)

Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen
por: Lai, Jennifer I, et al.
Publicado: (2018)

Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011)

Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index
por: Larsen, Martin, et al.
Publicado: (2012)

Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality
por: Mkhwanazi, Nompumelelo, et al.
Publicado: (2010)

Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011)

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies
por: Hua, Casey K., et al.
Publicado: (2017)

Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
por: Alter, Galit, et al.
Publicado: (2007)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
por: Jennewein, Madeleine F., et al.
Publicado: (2020)

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
por: Chu, Thach H., et al.
Publicado: (2020)

Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity
por: Lai, Jennifer I., et al.
Publicado: (2020)

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
por: Mahan, Alison E., et al.
Publicado: (2016)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
por: Mahan, Alison E., et al.
Publicado: (2016)

Systems serology: profiling vaccine induced humoral immunity against HIV
por: Chung, Amy W., et al.
Publicado: (2017)

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses
por: Riou, C, et al.
Publicado: (2012)

A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
por: Karsten, Christina B., et al.
Publicado: (2019)

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
por: Bradley, Todd, et al.
Publicado: (2017)

Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Computationally-driven identification of antibody epitopes
por: Hua, Casey K, et al.
Publicado: (2017)

Superior control of HIV-1 replication by CD8(+) T cells is reflected by their avidity, polyfunctionality, and clonal turnover
por: Almeida, Jorge R., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ff9p36u4cvd2kfgdrngv5sqj73